February 12, 2018
Article
Dysregulation of the JAK pathway plays a role in the development of numerous tumor types; it is particularly central to the pathophysiology of myelofibrosis and has long been recognized as a potentially valuable therapeutic target in that malignancy.
January 16, 2018
Article
Right-to-try legislation, which allows dying patients to take investigational medications without approval from the FDA.
January 14, 2018
Article
There is a critically important subject associated with the clinical trial experience that has had inadequate discussion within the medical literature, regarding the role of the patient beyond agreeing to serve as a research subject.
January 13, 2018
Article
Given that few options are available for intrahepatic cholangiocarcinoma, investigators are excited about a phase III trial of the multikinase inhibitor derazantinib as a second-line treatment for patients with inoperable or advanced disease.
January 13, 2018
Article
The effort to improve outcomes of disadvantaged patients involves every aspect of lung cancer care.
January 13, 2018
Article
Layering of therapies and advances in next-generation imaging and sequencing are key reasons that outcomes are improving in advanced prostate cancer.